Sarcopenia News and Research

RSS

New book explains about the molecular mechanisms implicated in skeletal muscle aging

Sarcopenia, the progressive loss of muscle mass and associated muscle weakness during aging, affects the functional capacity and general health in adult people radically and renders frail elders susceptible to serious injury from sudden falls and fractures.

21 Jul 2019

Researchers open the door to a new era of medicinal chemistry

Progress in the pharmaceutical industry depends largely on the achievements and advances in medicinal chemistry.

14 Jul 2019

Advances in artificial intelligence could shed light on aging process

There are two kinds of age: chronological age, w hich is the number of years one has lived, and biological age, which is influenced by our genes, lifestyle, behavior, the environment and other factors.

4 Jul 2019

Adequate consumption of milk and dairy products can help prevent chronic diseases

An adequate consumption of milk and dairy products at different life stages can help prevent various chronic diseases.

3 Jul 2019

New study sheds light on the role of vitamin D in muscle cells

A recent study conducted at The Westmead Institute for Medical Research has shed light on the role of vitamin D in muscle cells.

26 Jun 2019

Scientists enter research collaboration to find a cure for cancer

Cancer is a disease that afflicts an alarming number of people, with one in two being diagnosed with a type of cancer during their lifetime.

17 Apr 2019

Eating leafy green vegetables may help maintain muscle strength and mobility

Popeye was on to something. Eating just one cup of leafy green vegetables like spinach each day may help maintain muscle strength and mobility into old age.

25 Mar 2019

Latest advances and perspectives of all AI types used in pharmaceutical R&D

The advances in Artificial intelligence have successfully propagated into the many areas such as computer vision, speech recognition, and natural language processing.

19 Mar 2019

UTA nursing professor receives $6.575 million to attack musculoskeletal diseases

A University of Texas at Arlington College of Nursing and Health Innovation professor will use a series of grants totaling approximately $6.575 million during the next five years to attack a variety of debilitating musculoskeletal diseases.

18 Mar 2019

Australian women urged to increase physical activity and prevent chronic disease

To mark International Women’s Day on Friday 8 March, the Australian Physiotherapy Association is urging Australian women to place higher priority on their physical and mental health and wellbeing.

5 Mar 2019

Increased muscle mass could save your life

As far back as Ancient Greece, a sculptured physique has been heralded as the pinnacle of physical perfection. But now, researchers from Japan have found that increased muscle mass doesn't just make you look good, it could literally save your life.

4 Mar 2019

Mechanism behind how diabetes causes muscle loss revealed

Diabetes mellitus is associated with various health problems including decline in skeletal muscle mass. A research group led by Professor Wataru Ogawa at the Kobe University Graduate School of Medicine revealed that elevation of blood sugar levels leads to muscle atrophy and that two proteins, WWP1 and KLF15, play key roles in this phenomenon.

23 Feb 2019

Insilico to present its latest results in AI for Drug Discovery on CXOTalk Show

Insilico Medicine, a Rockville-based company developing the end-to-end drug discovery pipeline utilizing the next generation artificial intelligence, will present its latest results in modern and next-generation AI for Drug Discovery on a live episode of the influential CXOTalk Show on February 8, 2019 at 1:00 PM Eastern time.

1 Feb 2019

Loss of muscle and body weight linked with disability in stroke patients

Loss of muscle and body weight is associated with disability after stroke, reports a study presented today at Heart & Stroke 2019, a meeting of the European Society of Cardiology Council on Stroke, and published in the Journal of Cachexia, Sarcopenia and Muscle.

25 Jan 2019

Insilico Medicine to present latest advances in aging biomarker development at Longevity Leaders Conference

Insilico Medicine, a Rockville-based company developing the end-to-end drug discovery pipeline utilizing the next generation artificial intelligence, will present its latest advances in human aging biomarker development at the Longevity Leaders Conference in London, 4 of February.

25 Jan 2019

Insilico to present latest findings in AI for Drug Discovery at 3rd Annual SABPA FTD Forum

Insilico Medicine, a Rockville-based company developing the end-to-end drug discovery pipeline utilizing the next generation artificial intelligence, will present its latest results in modern and next-generation AI for Drug Discovery at the 3rd Annual SABPA FTD Forum in San Diego, California, 2 of February.

23 Jan 2019

Smoking significantly increases your biological age, study shows

Insilico Medicine, one of the leaders in artificial intelligence for drug discovery, biomarker development, digital medicine, and aging research, announced the publication of a new collaborative research paper titled "Blood Biochemistry Analysis to Detect Smoking Status and Quantify Accelerated Aging in Smokers" in Scientific Reports.

17 Jan 2019

Insilico Medicine and TARA Biosystems collaborate to develop novel therapies for cardiac diseases

Insilico Medicine, an artificial intelligence company developing end-to-end drug discovery pipelines for age-related diseases and TARA Biosystems, Inc. a company offering "heart-on-a-chip" tissue models for drug discovery and risk assessment applications, announced today the launch of a collaboration to discover and develop novel therapies for cardiac disease and diseases associated with cardiac muscle aging.

8 Jan 2019

Insilico to present 'AI-powered end-to-end pipelines for drug discovery' at Longevity Therapeutics 2019

Insilico Medicine, a Rockville-based company developing the end-to-end drug discovery pipeline utilizing the next generation artificial intelligence, will present its latest results in modern and next-generation AI for Drug Discovery at The Longevity Therapeutics 2019 in San Francisco, 30 of January.

30 Dec 2018

Latest advances in AI for aging and longevity research

Insilico Medicine, one of the leaders in artificial intelligence for drug discovery, biomarker development, digital medicine, and aging research announced today the publication of its recent paper titled "Artificial Intelligence for Aging and Longevity Research: Recent Advances and Perspectives" in Ageing Research Reviews, one of the highest-impact journals in the field.

3 Dec 2018